Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030.The manufacturing hub will produce Roche’s continuous glucose monitoring (CGM) systems for diabetes management.
The center will include…
What You Should Know:
– Abbott, a provider of continuous glucose monitoring (CGM) biowearable technology, has announced a landmark agreement with Epic Systems, a major provider of electronic health records (EHR).
– The first-of-its-kind collaboration for…
Continue Reading
What You Should Know:
– Sequel Med Tech, LLC, known for its innovative insulin delivery technology, and Senseonics Holdings, Inc., developer of long-term implantable continuous glucose monitoring (CGM) systems, announced a significant commercial development agreement.
–…
Continue Reading
Extended Wear CGM Innovation Redefines Diabetes Management
Dexcom has reached a significant milestone with FDA clearance for its G7 15-Day continuous glucose monitoring system for adults 18 and older. This next-generation device extends wear time…
What You Should Know:
– Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes…
Continue Reading
What You Should Know:
– Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18…
Continue Reading
Image by freepik
What You Should Know:
– New research published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association, reveals that patients receiving continuous glucose monitors (CGM) through durable medical equipment (DME) providers…
Continue Reading
What You Should Know:
– Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform’s capabilities with the integration of Abbott’s FreeStyle Libre continuous glucose monitoring…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, a leader in insulin delivery and diabetes technology announced the U.S. commercial launch of Control-IQ+ technology.
– This update provides users with greater flexibility and control over their…
Continue Reading
What You Should Know:
– Sequel Med Tech, LLC, a company focused on developing cutting-edge insulin delivery technologies, has announced that its innovative twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, will be the…
Continue Reading
